Investor update
Filed with ASX · · 2 pages · English
On 6ix: 6ix.com/news/investor-update-18
Genetic Signatures Ltd. on 6ix
Earlier from Genetic Signatures
- CE-IVD received for STI test
- Supply agreement with major US customer
- First quarter sales update
- Preliminary Final Report
- Quarterly report and Appendix 4C
Later from Genetic Signatures
- 3base SARS-CoV-2 kit registered by TGA for saliva samples
- S&P DJI Announces March 2022 Quarterly Rebalance
- Public Health Wales Awards Enteric Testing Contract to GSS
- Clinical trial recruitment completed for US enteric kit
- Full Year Statutory Accounts
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures